Abstract
Agnogenic myeloid metaplasia (AMM) is a disease characterized by bone marrow megakaryocyte hyperplasia and clusters of megakaryocytes, in which many of the megakaryocytes are atypical. In order to elucidate the mechanisms of megakaryocytosis, ELISA assays of blood levels of thrombopoietin (TPO), interleukin-6 (IL-6) and interleukin-11 (IL-11) were done in 45 patients with AMM and compared with normal volunteer controls. Higher blood TPO levels were found in AMM than in controls (Pā<ā0.0001), and blood tpo levels were correlated with the degree of marrow fibrosis (P = 0.0078). Blood levels of IL-6 were also significantly higher in AMM, when compared with controls (Pā<ā0.0001). however, no correlation was found between blood il-6 levels and degree of marrow fibrosis. no correlation was found between either tpo or il-6 and the number of blood platelet counts, the number of marrow megakaryocytes, wbc counts, or the degree of splenomegaly. blood il-11 levels were undetectable in most patients and no significant difference was found in amm as compared to controls. the present study demonstrated that, while in idiopathic thrombocytopenic purpura (itp) or aplastic anemia, blood tpo levels are relatively correlated with the numbers of platelet and/or megakaryocyte mass, blood tpo levels do not correlate with blood platelet counts, or marrow megakaryocyte mass in amm. therefore, in amm, other mechanisms such as the number of tpo receptors on platelets or megakaryocytes, c-mpl receptor abnormalities, abnormal production of tpo mrna and so on, will have to be studied. furthermore, tpo may play a significant role in the pathogenesis of marrow fibrosis; il-6 may be a factor in the development of marrow megakaryocytosis but its elevated blood levels may represent a secondary immune phenomenon; and il-11 probably does not play a significant role in causing marrow megakaryocytosis in this disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wang, J., Chen, C., Lou, LH. et al. Blood thrombopoietin, IL-6 and IL-11 levels in patients with agnogenic myeloid metaplasia. Leukemia 11, 1827ā1832 (1997). https://doi.org/10.1038/sj.leu.2400846
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2400846
Keywords
This article is cited by
-
Die Rolle von Interleukin-11 beimĀ Osteosarkom
Der Pathologe (2020)
-
Myeloproliferative leukemia protein activation directly induces fibrocyte differentiation to cause myelofibrosis
Leukemia (2017)
-
Involvement of transforming growth factor-Ī² and thrombopoietin in the pathogenesis of myelodysplastic syndrome with myelofibrosis
Leukemia (2005)
-
The Pathogenesis of Chronic Myeloproliferative Diseases
International Journal of Hematology (2001)
-
Molecular Defects in Chronic Myeloproliferative Disorders
Molecular Medicine (2000)